<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847485/" ref="ordinalpos=5031&amp;ncbi_uid=5574679&amp;link_uid=PMC3847485" image-link="/pmc/articles/PMC3847485/figure/F5/" class="imagepopup">Figure 5.  From: TLR9 <span class="highlight" style="background-color:">signaling</span> repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells. </a></div><br /><div class="p4l_captionBody"><b>TLR9 signaling induced the expression of HuR through Akt pathway.</b> 95D cells were treated with 50 μM PI3K inhibitor (LY294002) or specific MEK (Mitogen-activated protein kinase) inhibitor (U0126), 2.5 μM Akt inhibitor IV respectively, and then cultured in 24-well plate in the presence of 10 ug/ml CpG ODNs. 72 hrs later, the expression of HuR protein was determined by western blot and calculated <b>(A)</b>. <b>(B)</b> Schematic diagram for TLR9 signaling induced expression of HuR.</div></div>